Havedic Partners with Prevail to Advance AAVs for Neurological Disorders

Havedic Pharmaceutical is excited to announce a new partnership with Prevail Pharmaceutical to develop novel adeno-associated virus (AAV) capsids for disorders of the nervous system. (link)